TY  - CHAP
M1  - Book, Section
TI  - Chapter 1. Developing Perspectives on Pharmacogenomics
A1  - Hawke, Roy L.
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
Y1  - 2013
N1  - 
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - To  present  various  perspectives  on  pharmacogenomics,  from  the  professional  student  to  the  practitioner,  as  well  as  a  historical  perspective  on  this  rapidly  developing  field.  A  case  describing  a  potential  scenario  for  a  pharmacist  not  adequately  prepared  for  the  integration  of  pharmacogenomics  into  patient  care  is  provided.To  briefly  describe  the  origins  and  evolution  of  pharmacogenomics.To  discuss  the  reasons  why,  after  a  decade  of  research,  pharmacogenetics  and  individualized  therapy  have  not  yet  emerged  as  an  important  part  of  patient  care.To  offer  a  glimpse  of  the  future  where  increasingly  complex  technologies  and  more  rapid  advances  in  pharmacogenetic  research  will  simplify  the  use  of  a  patient's  genetic  variation  for  the  selection  of  drug  therapy  and  prediction  of  outcomes.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56875001
ER  -